Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,023) with videos related to
Page
of 103
Sort By:
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals
Nathan B Erdmann, Wilton B Williams, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The Lancet. HIV
|
June 15, 2018
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
Benjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Biorxiv : the Preprint Server for Biology
|
June 2, 2021
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
Aarthi Talla, Suhas V Vasaikar, Maria P Lemos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Allan C deCamp, Martin M Corcoran, William J Fulp, et al.
Journal of Cancer Research and Clinical Oncology
|
August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
NPJ Vaccines
|
March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Allan C deCamp, Martin M Corcoran, William J Fulp, et al.
Cell
|
May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Wilton B Williams, S Munir Alam, Gilad Ofek, et al.
Page
of 103
Search research articles
Search
Showing results (1011-1020 of 1,023) with videos related to
Sort By:
Page
of 103
The Journal of Clinical Investigation
|
February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 2, 2024
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals
Nathan B Erdmann, Wilton B Williams, Stephen R Walsh, et al.
The Lancet. Infectious Diseases
|
September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
The Lancet. HIV
|
June 15, 2018
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
Benjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Biorxiv : the Preprint Server for Biology
|
June 2, 2021
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
Aarthi Talla, Suhas V Vasaikar, Maria P Lemos, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Allan C deCamp, Martin M Corcoran, William J Fulp, et al.
Journal of Cancer Research and Clinical Oncology
|
August 8, 2023
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma
Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, et al.
NPJ Vaccines
|
March 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
Allan C deCamp, Martin M Corcoran, William J Fulp, et al.
Cell
|
May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
Wilton B Williams, S Munir Alam, Gilad Ofek, et al.
Page
of 103